血蛋白质组对血管痴呆风险的因果影响:一种带有实验验证的孟德尔随机化研究
Yunmeng Chen1, Chunyan Guo1, Xiao Liang1
1Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, 100091, China.
Cellular and molecular neurobiology
|July 7, 2025
概括
这项研究使用了门德尔的随机化方法,发现了9种与血管痴呆症 (VaD) 有因果关系的血蛋白. 确定了MED4和NRXN1作为关键蛋白质,显示了作为VaD生物标志物和治疗点的潜力.
科学领域:
- 遗传学 遗传学 是一个
- 神经学 神经学
- 生物化学 生物化学
背景情况:
- 血管痴呆症 (VaD) 是与脑血管疾病相关的认知障碍的常见原因.
- 血蛋白在VaD发育中的具体作用尚不清楚.
- 研究这些蛋白质可能会揭示对VaD病原体的新见解.
研究的目的:
- 探索循环等离子体蛋白质与患血管痴呆症 (VaD) 的风险之间的因果关系.
- 为了识别潜在的蛋白质生物标记物,用于VaD.
- 用实验动物模型验证发现.
主要方法:
- 用4907个血蛋白和VaD病例/对照组的全基因组关联研究 (GWAS) 数据进行了两样本的门德尔随机化 (MR) 分析.
- 逆方差加权 (IVW) 是主要的MR方法,得到了灵敏度分析的支持,包括加权中位数,MR-Egger和变性评估.
- 关键蛋白质的基因表达在使用定量实时PCR (qPCR) 的2血管封闭 (2-VO) 鼠标模型中得到验证.
主要成果:
- 在经过严格的统计纠正和灵敏度分析后,九种血蛋白与VaD风险存在强有力的因果关系.
- 确定MED4,COPS7B,CSF3,IL26,NRXN1,LRRTM4和MAGEA3是风险因素,MED4显示出最强的影响.
- 确定了CRYZL1和TMCC3作为对VaD的保护因素.
- 在2-VO模型中的实验验证显示MED4减少和NRXN1表达升高,与MR发现保持一致.
结论:
- 这项研究确定了特定的血蛋白和VaD之间的因果关系.
- 梅德4和NRXN1成为VaD生物标志物和治疗点的有希望的候选者.
- 需要进一步的研究来阐明VaD.中这些已识别的蛋白质的精确机制和临床实用性.
更多相关视频
05:30Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies
Published on: January 31, 2025
602
05:12A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis
Published on: November 22, 2024
706
相关概念视频
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
160
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
160
01:22Dementia l: Introduction
35
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35